Olgi network. J Virol 2009, 83:4574590. 29. Binette J, Dube M, Mercier J, Halawani D, Latterich M, Cohen EA: Needs for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus form 1 Vpu protein in the endoplasmic reticulum. Retrovirology 2007, 4:75. 30. Willey RL, Maldarelli F, Martin MA, Strebel K: Human immunodeficiency virus form 1 Vpu protein induces fast degradation of CD4. J Virol 1992, 66:7193200. 31. Magadan JG, Perez-Victoria FJ, Sougrat R, Ye Y, Strebel K, Bonifacino JS: Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting measures. PLoS Pathog 2010, 6:e1000869. 32. Lama J, Mangasarian A, Trono D: Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation within a Nef- and Vpuinhibitable manner. Curr Biol 1999, 9:62231. 33. Levesque K, Zhao YS, Cohen EA: Vpu exerts a optimistic impact on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells. J Biol Chem 2003, 278:283468353. 34. Wildum S, Schindler M, Munch J, Kirchhoff F: Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus form 1-infected T cells to superinfection. J Virol 2006, 80:8047059. 35. Shah AH, Sowrirajan B, Davis ZB, Ward JP, Campbell EM, Planelles V, Barker E: Degranulation of natural killer cells following interaction with HIV-1infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 2010, 8:39709. 36. Matusali G, Potesta M, Santoni A, Cerboni C, Doria M: The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol 2012, 86:4496504. 37. Sato K, Misawa N, Fukuhara M, Iwami S, An DS, Ito M, Koyanagi Y: Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice. J Virol 2012, 86:5000013. 38. Chang JJ, Altfeld M: Innate immune activation in principal HIV-1 infection. J Infect Dis 2010, 202:S297 301. 39. Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O: Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol 2007, 81:1000012. 40. Chen P, Hubner W, Spinelli MA, Chen BK: Predominant mode of human immunodeficiency virus transfer in between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol 2007, 81:125822595. 41. Zhong P, Agosto LM, Ilinskaya A, Dorjbal B, Truong R, Derse D, Uchil PD, Heidecker G, Mothes W: Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV. PLoS A single 2013, 8:e53138. 42.Foralumab Coleman CM, Spearman P, Wu L: Tetherin doesn’t significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef.Chloroquine phosphate Retrovirology 2011, 8:26.PMID:23255394 43. Galao RP, Le Tortorec A, Pickering S, Kueck T, Neil SJ: Innate sensing of HIV1 assembly by tetherin induces NFkappaB-dependent proinflammatory responses. Cell Host Microbe 2012, 12:63344. 44. Lindwasser OW, Chaudhuri R, Bonifacino JS: Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses. Curr Mol Med 2007, 7:17184.45. Sauter D, Unterweger D, Vogl M, Usmani SM, Heigele A, Kluge SF, Hermkes E, Moll M, Barker E, Peeters M, et al: Human tetherin exerts powerful choice stress on the HIV-1 group N Vpu protein. PLoS Pathog 2012, 8:e1003093. 46. Sauter D, Schindler.
